These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3127243)
21. Variability and selectivity of anterior pituitary response to dopamine agonists throughout the normal menstrual cycle. Kletzky OA; Shangold GA Am J Obstet Gynecol; 1986 Feb; 154(2):362-7. PubMed ID: 3080890 [TBL] [Abstract][Full Text] [Related]
22. Influence of lisuride, a dopaminergic agonist, on the sexual function of male patients with chronic renal failure. Ruilope L; Garcia-Robles R; Paya C; de Villa LF; Miranda B; Morales JM; Parada J; Sancho J; Rodicio JL Am J Kidney Dis; 1985 Mar; 5(3):182-5. PubMed ID: 3919573 [TBL] [Abstract][Full Text] [Related]
23. Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. Lal S; Tolis G; Martin SB; Brown GM; Guyda H J Clin Endocrinol Metab; 1975 Nov; 41(5):827-32. PubMed ID: 1184719 [TBL] [Abstract][Full Text] [Related]
24. Effects of lisuride and bromocriptine on inhibition of lactation and on serum prolactin levels: comparative double-blind study. Venturini PL; Horowski R; Maganza C; Morano S; Pedretti E; Ragni N; Semino F; De Cecco L Eur J Obstet Gynecol Reprod Biol; 1981 May; 11(6):395-400. PubMed ID: 7018950 [TBL] [Abstract][Full Text] [Related]
25. Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kinetics. Borges JL; Schran HF; Evans WS; Rogol AD; Kaiser DL; MacLeod RM; Boyett RL; Elton RL; Thorner MO Clin Pharmacol Ther; 1984 Nov; 36(5):696-703. PubMed ID: 6386276 [TBL] [Abstract][Full Text] [Related]
26. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model]. Tresguerres JA; Esquifino AI Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409 [TBL] [Abstract][Full Text] [Related]
27. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women]. Masaoka K; Hosoya N; Mori T; Watanabe H; Ohkura T; Kumasaka T Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310 [TBL] [Abstract][Full Text] [Related]
28. [Effects of the partial dopamine receptor agonist, terguride, on the field-stimulated vas deferens in the mouse]. Carratù MR; De Serio A; Lagioia R; Conte-Camerino D; Ferrari E; Mitolo-Chieppa D Boll Soc Ital Biol Sper; 1990 Jan; 66(1):35-42. PubMed ID: 1969741 [TBL] [Abstract][Full Text] [Related]
29. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women. Bohnet HG; Kato K; De Moll H Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541 [TBL] [Abstract][Full Text] [Related]
30. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins. Dawood MY; Jarrett JC; Choe JK Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states. Verde G; Chiodini PG; Liuzzi A; Cozzi R; Favales F; Botalla L; Spelta B; Dalla Bonzana D; Rainer E; Horowski R J Endocrinol Invest; 1980; 3(4):405-14. PubMed ID: 6782153 [TBL] [Abstract][Full Text] [Related]
32. Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride. Stracke H; Heinlein W; Horowski R; Schatz H Arzneimittelforschung; 1986 Dec; 36(12):1834-6. PubMed ID: 3566845 [TBL] [Abstract][Full Text] [Related]
33. Rapid regression of macroprolactinomas by the new dopamine partial agonist terguride. Gräf KJ; Köhler D; Horowski R; Dorow R Acta Endocrinol (Copenh); 1986 Apr; 111(4):460-6. PubMed ID: 3085417 [TBL] [Abstract][Full Text] [Related]
34. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study. Verhelst JA; Froud AL; Touzel R; Wass JA; Besser GM; Grossman AB Acta Endocrinol (Copenh); 1991 Oct; 125(4):385-91. PubMed ID: 1683503 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of hyperprolactinemia and acromegaly with lisuride]. Berezin M; Elchalal U; Olchovsky D Harefuah; 1989 Jun; 116(12):634-7. PubMed ID: 2792946 [TBL] [Abstract][Full Text] [Related]